Seeking Alpha

With the FDA fast-tracking J&J's (JNJ) psoriasis drug, Amgen (AMGN) - whose Enbrel dominates...

With the FDA fast-tracking J&J's (JNJ) psoriasis drug, Amgen (AMGN) - whose Enbrel dominates 80% of the market - should be worried.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector